...
首页> 外文期刊>International Journal of Nursing Sciences >Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease
【24h】

Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease

机译:中文版评估间质性肺病患者特发性肺纤维化生活质量的工具的信度和效度

获取原文
   

获取外文期刊封面封底 >>

       

摘要

ObjectiveThis paper aims to determine the reliability and validity of the Chinese version of a tool that assesses the quality of life in idiopathic pulmonary fibrosis (cATAQ-IPF) in patients with interstitial lung disease (ILD).MethodsWe used the process of scale introduction to establish cATAQ-IPF. The content validity of the scale was evaluated by six experts. A total of 92 patients with ILD completed the cATAQ-IPF, St. George's respiratory questionnaire (SGRQ), and The Medical Research Council dyspnoea scale at the baseline, and 15 patients completed cATAQ-IPF at the follow-up period 2 weeks later. Thus, yielding data were used to assess various psychometric properties of cATAQ-IPF. Intraclass correlation coefficient (ICC), Cronbach's α coefficient, content validity index (CVI), item-level CVI (I-CVI), Pearson's coefficients, criterion-relation validity, and known-group validity were used for data analysis.ResultsThe cATAQ-IPF showed excellent test–retest reliability (ICC?=?0.95), except for the therapy domain (Cronbach's α?=?0.60) and acceptable internal consistency (Cronbach's α?=?0.96 for the total). The scale-level CVI was 0.80, and the I-CVI was in the range of 0.78–1.00. The total cATAQ-IPF score was strongly correlated with the SGRQ total score (r?=?0.71,P?
机译:目的本文旨在确定中文版评估间质性肺疾病(ILD)患者特发性肺纤维化(cATAQ-IPF)生活质量的工具的可靠性和有效性。 cATAQ-IPF。该量表的内容效度由六位专家评估。共有92例ILD患者在基线完成了cATAQ-IPF,圣乔治呼吸问卷(SGRQ)和医学研究委员会的呼吸困难量表,15例患者在2周后的随访中完成了cATAQ-IPF。因此,屈服数据用于评估cATAQ-IPF的各种心理测量特性。使用类内相关系数(ICC),克朗巴赫(Cronbach)α系数,内容有效性指数(CVI),项目级CVI(I-CVI),皮尔逊系数,标准关系有效性和已知组有效性进行数据分析。 IPF显示出极好的重测信度(ICC?=?0.95),除了治疗范围(Cronbach'sα?=?0.60)和可接受的内部一致性(Cronbach'sα?=?0.96)。规模CVI为0.80,而I-CVI在0.78-1.00之间。 cATAQ-IPF总得分与SGRQ总得分高度相关(r?=?0.71,P?<?0.01)。 ILD患者的cATAQ-IPF评分为250.74?±?47.39,IPF患者的cATAQ-IPF评分为287.90?±?22.56。根据cATAQ-IPF评分,IPF患者的健康相关生活质量存在相当大的损害(t?=?4.94,P?<?0.01)。结论cATAQ-IPF是一种可靠且有效的评估患者质量的工具各种形式ILD的中国患者的生活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号